NKGen Biotech Korea엔케이젠바이오텍코리아
182400 · KOSDAQ · ₩182400 · 엔케이젠바이오텍코리아
₩3,670 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Amended: Half-year report (Jun 2026)[기재정정]반기보고서 (2026.06)Sep 30, 2026Open on DART
- Added attachment: Half-year report (Jun 2026)[첨부추가]반기보고서 (2026.06)Aug 13, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Amended: Change of largest shareholder[기재정정]최대주주변경을수반하는주식담보제공계약체결Apr 22, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 22, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
- [Amended Filing] Notice on Appointment, Dismissal or Mid-Term Departure of Independent Director[기재정정]독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 31, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 31, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Mar 24, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 24, 2026Open on DART
- Other Market Notice (No Market Measures Taken Regarding Partial Lifting of Reasons for Administrative Issue and Investment Caution Designation)기타시장안내 (관리종목 및 투자주의 환기종목 사유 일부 해제 관련 시장조치 미진행)Mar 23, 2026Open on DART
- Audit report submitted감사보고서제출Mar 23, 2026Open on DART
- Amended: Audit report submitted[기재정정]감사보고서제출 (2024사업연도)Mar 23, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 16, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 16, 2026Open on DART
- Delisting내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생Feb 27, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Feb 19, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Feb 19, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure) (Third-Party Allotment Rights Offering)증권발행결과(자율공시) (제3자배정 유상증자)Feb 2, 2026Open on DART
- Capital Reduction Completed감자완료Jan 30, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jan 22, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jan 20, 2026Open on DART
- Amended: Capital reduction decision[기재정정]주요사항보고서(감자결정)Jan 20, 2026Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Jan 15, 2026Open on DART
- Change of largest shareholder최대주주변경을수반하는주식담보제공계약체결Jan 12, 2026Open on DART
- Other management matters기타경영사항(자율공시) (상장폐지결정등 효력정지 가처분신청)Jan 7, 2026Open on DART
- Trading halt주권매매거래정지 (투자자보호)Jan 7, 2026Open on DART
- Other Market Notice (Regarding Postponement of Clearance Sale)기타시장안내 (정리매매 보류 관련)Jan 7, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jan 7, 2026Open on DART
- Delisting기타시장안내 (코스닥시장위원회 개최 결과 및 상장폐지 결정 안내)Jan 6, 2026Open on DART
- Delisting주권매매거래정지해제 (상장폐지에 따른 정리매매 개시)Jan 6, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure) (Third-Party Allotment Rights Offering)증권발행결과(자율공시) (제3자배정 유상증자)Dec 30, 2025Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Dec 30, 2025Open on DART
- Amended: Capital reduction decision[기재정정]주요사항보고서(감자결정)Dec 22, 2025Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Dec 17, 2025Open on DART
- Rights offering (paid-in capital increase) decision유상증자결정 (출자전환)Dec 15, 2025Open on DART
- Delisting기타시장안내 (상장폐지 관련 이의신청서 접수)Dec 10, 2025Open on DART
- Amended: Quarterly report (Sep 2025)[기재정정]분기보고서 (2025.09)Dec 4, 2025Open on DART
- Change of Head Office Location본점소재지변경Nov 21, 2025Open on DART
- Notice of Company Name Change상호변경안내Nov 21, 2025Open on DART
- Results of Extraordinary Shareholders' Meeting임시주주총회결과Nov 21, 2025Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Nov 21, 2025Open on DART
- Amended: Shareholders' meeting called[기재정정]주주총회소집결의 (임시주주총회)Nov 20, 2025Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Nov 20, 2025Open on DART
- Delisting주권매매거래정지기간변경 (상장폐지 사유 발생)Nov 19, 2025Open on DART
- Other Market Notice (Announcement of Results of Corporate Review Committee Meeting)기타시장안내 (기업심사위원회 개최 결과 안내)Nov 19, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Lawsuit filed or ruled소송등의판결ㆍ결정(일정금액이상의청구)Nov 6, 2025Open on DART
- Amended: Shareholders' meeting called[기재정정]주주총회소집결의 (임시주주총회)Nov 6, 2025Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Nov 6, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: NKGen Biotech Korea / 엔케이젠바이오텍코리아 / 182400 / KRX:182400
Source: KRX statistical information